UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 24, 2003
CELGENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-16132 22-2711928
--------------------------------------------------------------------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
7 Powder Horn Drive, Warren, New Jersey 07059
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 271-1001
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibit 99.1 - Press Release dated July 24, 2003.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On July 24, 2003, Celgene Corporation announced its earnings for the
quarter ended June 30, 2003. Attached hereto and incorporated herein by
reference as Exhibit 99.1 is the Press Release announcing such results.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CELGENE CORPORATION
Date: August 4, 2003 By: /s/ Robert J. Hugin
---------------------------------
Name: Robert J. Hugin
Title: Senior Vice President and
Chief Financial Officer